Owlstone Medical

To add a bio or update company history, please click update information.

News from Owlstone Medical

Owlstone Medical wins £36m award from US Gov ARPA-H programme to develop at-home cancer detection tests

6 Oct 2025

Owlstone Medical wins £36m award from US Gov ARPA-H programme to develop at-home cancer detection tests

Owlstone Medical develops breath-based diagnostic technologies that detect disease using chemical markers, enabling non-invasive screening and monitoring for cancer and chronic conditions at home or point of care.

Owlstone Medical

Life Sciences
Cambridge, United Kingdom
£36m
owlstonemedical.com
Update Information

More venture news

Basecamp Research
23 Sept 2026
Basecamp Research unlocks £105m Series C led by S32 to design medicines with frontier AI models
Series CLife Sciences
Big Picture Bio
18 Sept 2026
Big Picture Bio raises a £1.5m pre-seed round led by Kadmos Capital and Exceptional Ventures to design cancer combination therapies
Pre-seedLife Sciences
Eterna Regeneratives
16 Sept 2026
Eterna Regeneratives closes a seed round led by Hoxton Ventures and The Venture Collective to develop keratin-based enamel repair
SeedLife Sciences

Owlstone Medical

News from Owlstone Medical

Owlstone Medical wins £36m award from US Gov ARPA-H programme to develop at-home cancer detection tests

More venture news

Basecamp Research unlocks £105m Series C led by S32 to design medicines with frontier AI models

Big Picture Bio raises a £1.5m pre-seed round led by Kadmos Capital and Exceptional Ventures to design cancer combination therapies

Eterna Regeneratives closes a seed round led by Hoxton Ventures and The Venture Collective to develop keratin-based enamel repair